Literature DB >> 33130007

Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit.

Henry P Parkman1, Emily Sharkey2, Richard W McCallum3, William L Hasler4, Kenneth L Koch5, Irene Sarosiek3, Thomas L Abell6, Braden Kuo7, Robert J Shulman8, Madhusudan Grover9, Gianrico Farrugia9, Ron Schey10, James Tonascia2, Frank Hamilton11, Pankaj J Pasricha2.   

Abstract

BACKGROUND & AIMS: Constipation can be an important symptom in some patients with gastroparesis. The aims were to: 1) Determine prevalence of constipation and delayed colonic transit in patients with symptoms of gastroparesis; 2) Correlate severity of constipation to severity of symptoms of gastroparesis; and 3) Relate severity of constipation to GI transit delays assessed by gastric emptying scintigraphy (GES) and wireless motility capsule (WMC).
METHODS: Patients with symptoms of gastroparesis underwent gastric emptying scintigraphy (GES), wireless motility capsule (WMC) assessing gastric emptying, small bowel transit, and colonic transit, and questionnaires assessing symptoms using a modified Patient Assessment of Upper GI Symptoms [PAGI-SYM] and Rome III functional GI disorder questionnaire.
RESULTS: Of 338 patients with symptoms of gastroparesis, 242 (71.5%) had delayed gastric emptying by scintigraphy; 298 (88.2%) also met criteria for functional dyspepsia. Severity of constipation was severe/very severe in 34% patients, moderate in 24%, and none/very mild/mild in 42%. Increasing severity of constipation was associated with increasing symptoms of gastroparesis and presence of irritable bowel syndrome (IBS). Severity of constipation was not associated with gastric retention on GES or WMC. Delayed colonic transit was present in 108 patients (32% of patients). Increasing severity of constipation was associated with increasing small bowel transit time, colonic transit time, and whole gut transit time.
CONCLUSIONS: Severe/very severe constipation and delayed colon transit occurs in a third of patients with symptoms of gastroparesis. The severity of constipation is associated with severity of gastroparesis symptoms, presence of IBS, small bowel and colon transit delay, but not delay in gastric emptying. ClinicalTrials.gov Identifier: NCT01696747.
Copyright © 2022 AGA Institute. All rights reserved.

Entities:  

Keywords:  Constipation; Delayed Colonic Transit; Delayed Gastric Emptying; Gastroparesis; Irritable Bowel Syndrome

Mesh:

Year:  2020        PMID: 33130007      PMCID: PMC8079462          DOI: 10.1016/j.cgh.2020.10.045

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  21 in total

Review 1.  American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis.

Authors:  Henry P Parkman; William L Hasler; Robert S Fisher
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

2.  Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying.

Authors:  Pankaj J Pasricha; Ryan Colvin; Katherine Yates; William L Hasler; Thomas L Abell; Aynur Unalp-Arida; Linda Nguyen; Gianrico Farrugia; Kenneth L Koch; Henry P Parkman; William J Snape; Linda Lee; James Tonascia; Frank Hamilton
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

3.  Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice.

Authors:  G J Kolar; M Camilleri; D Burton; A Nadeau; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2013-10-10       Impact factor: 3.598

4.  Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms.

Authors:  E S Bonapace; A H Maurer; S Davidoff; B Krevsky; R S Fisher; H P Parkman
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

5.  Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility.

Authors:  Satish S C Rao; Krupa Mysore; Ashok Attaluri; Jessica Valestin
Journal:  J Clin Gastroenterol       Date:  2011-09       Impact factor: 3.062

6.  Assessment of gastric emptying using a low fat meal: establishment of international control values.

Authors:  G Tougas; E Y Eaker; T L Abell; H Abrahamsson; M Boivin; J Chen; M P Hocking; E M Quigley; K L Koch; A Z Tokayer; V Stanghellini; Y Chen; J D Huizinga; J Rydén; I Bourgeois; R W McCallum
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

7.  Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.

Authors:  D A Revicki; A M Rentz; D Dubois; P Kahrilas; V Stanghellini; N J Talley; J Tack
Journal:  Aliment Pharmacol Ther       Date:  2003-07-01       Impact factor: 8.171

8.  The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology.

Authors:  I Sarosiek; K H Selover; L A Katz; J R Semler; G E Wilding; J M Lackner; M D Sitrin; B Kuo; W D Chey; W L Hasler; K L Koch; H P Parkman; J Sarosiek; R W McCallum
Journal:  Aliment Pharmacol Ther       Date:  2009-10-08       Impact factor: 8.171

9.  High Prevalence of Slow Transit Constipation in Patients With Gastroparesis.

Authors:  Thomas A Zikos; Afrin N Kamal; Leila Neshatian; George Triadafilopoulos; John O Clarke; Monica Nandwani; Linda A Nguyen
Journal:  J Neurogastroenterol Motil       Date:  2019-04-30       Impact factor: 4.924

10.  The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference.

Authors:  Y Yiannakou; J Tack; H Piessevaux; D Dubois; E M M Quigley; M Y Ke; S Da Silva; A Joseph; R Kerstens
Journal:  Aliment Pharmacol Ther       Date:  2017-10-06       Impact factor: 8.171

View more
  4 in total

1.  ACG Clinical Guideline: Gastroparesis.

Authors:  Michael Camilleri; Braden Kuo; Linda Nguyen; Vida M Vaughn; Jessica Petrey; Katarina Greer; Rena Yadlapati; Thomas L Abell
Journal:  Am J Gastroenterol       Date:  2022-06-03       Impact factor: 12.045

2.  Prevalence and clinical correlates of antinuclear antibody in patients with gastroparesis.

Authors:  Henry P Parkman; Mark L Van Natta; Ashima Makol; Madhusudan Grover; Richard W McCallum; Zubair Malik; Kenneth L Koch; Irene Sarosiek; Braden Kuo; Robert J Shulman; Gianrico Farrugia; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha; Thomas L Abell
Journal:  Neurogastroenterol Motil       Date:  2021-10-01       Impact factor: 3.960

3.  Comment on Suresh et al. The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study. Nutrients 2021, 13, 4298.

Authors:  J Wesley Jones; Katrina Lamont; Grace D Brannan
Journal:  Nutrients       Date:  2022-04-28       Impact factor: 6.706

4.  Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls.

Authors:  Dag A Sangnes; Katarina Lundervold; Mattis Bekkelund; Hilde L von Volkmann; Birgitte Berentsen; Odd Helge Gilja; Georg Dimcevski; Eirik Søfteland
Journal:  United European Gastroenterol J       Date:  2021-10-23       Impact factor: 4.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.